ACE and COVID-19: In their study on Greek population, Papadopoulou et al. (2022[38]) found differences in ACE1 activity related to genotypes between patients with COVID-19 and control subjects, and suggested a more complex and disease-specific relation between ACE1 genotypes, activity of ACE1 and disease progression.